Overview

Efficacy and Safety Study of Thioctacid Oral Tablets 600mg to Treat Chinese Diabetic Patients With Distal Symmetric Polyneuropathy

Status:
Unknown status

Trial end date:
2011-07-01

Target enrollment:

Participant gender:

Summary

The purpose of the study is to evaluate the efficacy on overall neuropathic sensory symptom improvement of Thioctacid tablet 600mg once daily vs. placebo in 6-weeks' treatment in Chinese diabetic patients with distal symmetric polyneuropathy (DSP).

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

NovaMed Pharmaceuticals Inc.

Treatments:

Thioctic Acid